{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T17:16:21Z","timestamp":1781111781010,"version":"3.54.1"},"reference-count":17,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2011,2,25]],"date-time":"2011-02-25T00:00:00Z","timestamp":1298592000000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2011,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\/Aims:<\/jats:bold> Treatment with high\u2010dose cisplatin (HDC) previously required inpatient (IP) admission with overnight hospitalization, but recently practice has shifted to outpatient (OP) therapy. We aimed to determine whether it is preferable to give HDC as an IP or OP using a two\u2010period cross\u2010over trial.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Eligible patients were starting chemotherapy with \u22652 cycles of HDC (\u2265100\u2003mg\/dose) and were suitable for OP treatment. All patients received an IP cycle and OP cycle: the order was randomly allocated. Pre\u2010hydration, anti\u2010emetics and chemotherapy were identical for IP and OP. Post\u2010hydration varied by group (3\u2003L normal saline (NS) for IP, 2\u2003L NS for OP). The primary outcome was patient preference for IP versus OP treatment. Secondary outcomes included aspects of health\u2010related quality of life, adverse events (dose delays and reductions, elevated creatinine and unplanned readmissions) and resource use.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Fifty\u2010nine patients were randomized, 53 completed two cycles of HDC. Most patients preferred OP treatment (36 vs 13, <jats:italic>P<\/jats:italic>= 0.002). There were no significant differences in patients' ratings of nausea, vomiting, fatigue, anxiety, depression or overall quality of life. Adverse events were few and unrelated to IP versus OP treatment. Nursing time was longer for IP than OP (163 vs 104\u2003min, <jats:italic>P<\/jats:italic> &lt; 0.001).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> OP treatment was preferred by most patients, appeared safe and used less resources.<\/jats:p>","DOI":"10.1111\/j.1445-5994.2010.02201.x","type":"journal-article","created":{"date-parts":[[2010,2,26]],"date-time":"2010-02-26T11:06:23Z","timestamp":1267182383000},"page":"172-178","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Randomized cross\u2010over trial comparing inpatient and outpatient administration of high\u2010dose cisplatin"],"prefix":"10.1111","volume":"41","author":[{"given":"K. M.","family":"Cox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. L.","family":"O'Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. J.","family":"Beale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Simes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. R.","family":"Stockler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.10.1379"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(78)90825-2"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.095"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600884"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002786"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00365584"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1089\/sct.1989.5.137"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.annonc.a057724"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(97)91176-4"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1979.tb05903.x"},{"key":"e_1_2_5_13_2","unstructured":"GrusenmeyerPA GrallaRJ TrapaniMM BatemanMM.Alternatives to inpatient care: a cost comparison of home versus outpatient clinic care for chemotherapy administration and supportive care measures (abstract). American Society of Clinical Oncology Annual Meeting 1996; Abstr 926."},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2008.26.15_suppl.20737","article-title":"Safe and rapid outpatient administration of cisplatin >75\u2003mg\/m2 for lung cancer","volume":"26","author":"Lavola A","year":"2008","journal-title":"J Clin Oncol"},{"key":"e_1_2_5_15_2","unstructured":"StathopoulosGP MalamosNA PapakostasP MoschopoulosN SamelisGF MichailakisE.Treatment of non\u2010small cell lung cancer with cisplatin combination on an outpatient basis. Effectiveness toxicity and cost benefit. American Society of Clinical Oncology Annual Meeting 1995; Abstr 1181."},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00417474"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19890101)63:1<30::AID-CNCR2820630105>3.0.CO;2-M"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.2000.5810"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1445-5994.2010.02201.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1445-5994.2010.02201.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T11:27:04Z","timestamp":1697369224000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1445-5994.2010.02201.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1111\/j.1445-5994.2010.02201.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1445-5994.2010.02201.x","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"2011-02-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}